This content is intended for healthcare professionals only. Please confirm that you are a healthcare professional.

Decline

This activity has been sponsored by GW Pharmaceuticals. GW Pharmaceuticals provided financial support and has had input into the selection of the faculty and/or the detailed project scope.  This activity is provided by Touch Medical Communications (TMC) for touchNEUROLOGY.

Epilepsy American Epilepsy Society (AES) 2020 Congress Watch Time: 56 mins

touchCONFERENCE Key developments in the diagnosis, treatment and understanding of childhood-onset, treatment-resistant epilepsies with Dr Antonietta Coppola & Dr Angel Aledo-Serrano

Watch this two-part activity discussing diagnostic and therapeutic advances in the field of childhood-onset treatment-resistant epilepsy from AES 2020

Part 1: Watch internationally renowned expert Dr Antonietta Coppola review key data from the conference focussing on genetic diagnosis and treatments Watch Now
Part 2: Choose from two leading experts who discuss how data presented at the AES 2020 may affect daily practice Select An Interview

  • Part 1: Review of highlights from the congress
Next Chapter
Introduction
Watch Time: 00:00
Unmet need and recent advances in our understanding of childhood-onset epilepsies
Watch Time: 01:10
Promising advances in the diagnosis and treatment of childhood-onset, treatment-resistant epilepsies
Watch Time: 09:35
The impact of COVID-19 and current outlook for people with childhood-onset epilepsies
Watch Time: 24:14
Video Player Controls:
 
  • Part 2: Expert Interviews
Leave Feedback
Dr Antonietta Coppola
Watch Time: 14:00
Department of Neurosciences, Federico II University, Naples, Italy

Dr Antonietta Coppola discusses advances in our genetic understanding and management of early-onset epilepsies.

 
Leave Feedback
Overview

Watch Dr Antonietta Coppola discuss key developments in the diagnosis, treatment and understanding of childhood-onset, treatment-resistant epilepsies presented at AES 2020.

About Dr Antonietta Coppola

Dr Antonietta Coppola is Assistant Professor of Neurology at the Department of Neuroscience, Reproductive and Odontostomatological Sciences at the University of Naples Federico II, Italy. She is a member of the Italian chapter of the International League Against Epilepsy (ILAE). Her main area of expertise is the diagnosis and treatment of genetically determined epilepsies. She has authored around 100 peer-reviewed articles and book chapters, and serves on the editorial boards of several scientific journals.

Disclosures: Dr Coppola has received consultancy fees from EISAI and GW pharmaceuticals and travel sponsorship from UCB.

Interview Questions

In this interview Dr Antonietta Coppola addresses the following questions:

  • How has our genetic understanding of early-onset epilepsies advanced diagnostic and therapeutic approaches?
  • What is the long-term prognosis for people with epilepsies secondary to an underlying genetic condition?
  • In your opinion, what were the key diagnostic and therapeutic advances presented at AES 2020 for these patient populations?
  • Which therapeutic developments would you incorporate into your daily practice?
Dr Angel Aledo-Serrano
Watch Time: 10:00
Neurology Department, Ruber Internacional Hospital, Madrid, Spain

Dr Angel Aledo-Serrano discusses recent therapeutic advances in treatment-resistant, childhood-onset epilepsies.

 
Leave Feedback
Overview

Watch leading experts discuss the key developments in the diagnosis, treatment and understanding of childhood-onset, treatment resistant epilepsies presented at the virtual American Epilepsy Society (AES) congress, 2020.

About Dr Angel Aledo-Serrano

Dr Angel Aledo-Serrano MD, PhD has a clinical and research focus in complex paediatric and adult epilepsies, and works at two Comprehensive Epilepsy Centers in Spain: the Ruber Internacional Hospital (Madrid) and Corachan Clinic (Barcelona). He is also Associate Professor at Autonoma, Camilo Jose Cela and Francisco de Vitoria Universities in Madrid. Dr Aledo-Serrano is involved in research projects covering different fields of refractory epilepsy, such as epilepsy surgery, electro-clinical phenotyping, includingeHe is coordinator of the Young Epilepsy Section of the Spanish Epilepsy Society and has collaborated with the ILAE to improve epilepsy education through Social Media. He is highly active in the social aspects of patients and families with developmental and epileptic encephalopathies in different areas, such as scientific advisory activities and collaborations with patient advocacy groups.

Disclosures: Funding for research and educational activities from GW, UCB, Sanofi, Bial, Eisai, Arvelle, and Zogenix.

Interview Questions

In this interview, Dr Angel Aledo-Serrano addresses the following questions:

  • What are the main challenges in the management of treatment-resistant childhood-onset epilepsies?
  • What is the long-term prognosis for people with these conditions?
  • In your opinion, what were the most promising therapies presented at the AES 2020 from a pharmacological, non-pharmacological, lifestyle management, and surgical perspective?
  • Are we closer to “precision medicine” in the epilepsy field after the advances presented at the AES 2020?
  • Which of these would you incorporate into your daily practice?
Please Select A Video:
Leave Feedback
Overview & Learning Objectives
Overview

Watch leading experts discuss the key developments in the diagnosis, treatment and understanding of childhood-onset, treatment resistant epilepsies presented at the virtual American Epilepsy Society (AES) congress, 2020.

Learning Objectives

After watching this touchCONFERENCE activity, you should be able to:

  • Recognise the unmet needs and challenges that remain for people living with childhood-onset, treatment-resistant epilepsies.
  • Understand the challenges that remain in the management and monitoring of the childhood-onset epilepsies, and be aware of the key diagnostic advances presented at AES 2020.
  • Describe the key therapeutic developments for childhood-onset, treatment-resistant epilepsies presented at AES 2020.
Downloads

View and download resources from this activity to support your learning or share with colleagues.

Feedback Close
Feedback

Please provide feedback for this touchCONFERENCE on the following
(scale 1-5, 1 strongly disagree; 5 strongly agree):

Feedback Close
Copied to clipboard!
accredited arrow-downarrow_leftarrow-right-bluearrow-right-dark-bluearrow-right-greyarrow-right-orangearrow-right-whitearrow-right-blueavatarcalendarchevron-down consultant-pathologist-nurseconsultant-pathologistcrosscrossdownloademailexclaimationfeedbackfiltergraph-arrowinterviewslinkmenumore_dots nurse-consultantpadlock patient-advocate-pathologistpatient-consultantpatientperson pharmacist-nurseplay_buttonplay-colour-tmcplay-colourAsset 1podcastprinter scenerysearch share social_facebooksocial_googleplussocial_instagramsocial_linkedin_altsocial_linkedin_altsocial_pinterestlogo-twitter-glyph-32social_youtubeshape-star (1)tick-bluetick-orangetick-whiteticktimetranscriptup-arrowwebinar